Our objective is to offer screening tests to the medical community to address the rapidly spreading metabolic disorders and their associated complications.
SUDOSCAN® Device -The patented technology behind the SUDOSCAN® device is designed to assess sudomotor function by evaluating sweat gland activity. The procedure is non-invasive and works by measuring the release of chloride ions from sweat glands in response to an electrical stimulus. Conductance measurements are taken on the palms of the hands and the soles of the feet, which are linked to the status of small nerve fibers that innervate sweat glands. Small fiber neuropathy is common in the early stages of diabetes and prediabetes. SUDOSCAN® has developed a proven proprietary technology that enables the early detection of neuropathies caused by diabetes complications, even when the condition is still reversible. The technology also allows for easy and quantifiable monitoring of a patient's neuropathic complications over time.
Our mission is to offer innovative and distinctive medical devices to enhance the management and treatment of diabetes and conditions resulting in neuropathies. We strive to provide patients and healthcare professionals with novel tools that aid in improving disease management and overall quality of life.